Tehran University of Medical Sciences

Science Communicator Platform

Share By
Evaluation of Mir-155 Expression in Peripheral Blood Samples of Copd Patients Publisher



Mohamadnia A ; Bayat M ; Dargahi H ; Shafaghi S ; Karimi R ; Saleh MSS ; Soltani MH ; Tehrani MM ; Ahmadi F ; Bahrami N
Authors

Source: Journal of Craniomaxillofacial Research Published:2025


Abstract

Introduction: Chronic obstructive pulmonary disease (COPD) is a progressive, irreversible chronic inflammatory disorder characterized by the increased recruitment of monocytes, lymphocytes, and neutrophils. Beyond the lungs, COPD is associated with systemic inflammation, skeletal complications such as osteoporosis, and poor oral and periodontal health, all of which are clinically relevant in oral and maxillofacial practice. This study aims to investigate the changes in miR-155 expression in the peripheral blood of COPD patients compared to healthy individuals. Materials and Methods: In this descriptive-cross-sectional study, 35 peripheral blood samples from COPD patients and 35 peripheral blood samples from healthy individuals were collected. RNA extraction was immediately performed, followed by Real-Time PCR to assess the changes in miR-155 expression. Results: The miR-155 biomarker was positive in the peripheral blood of 25 out of 35 patients. In the group of healthy individuals, this biomarker was positive in 6 out of 35 cases. Statistical analysis of the positivity rate of this biomarker between the patient group and the healthy group showed a significant difference. Based on the findings of this study, the expression of miR-155 is increased in COPD patients compared to healthy individuals. Conclusion: The miR-155 biomarker could potentially play an important role in the identification and diagnosis of COPD in patients. Given the growing evidence that COPD-related systemic and oral inflammation adversely affects periodontal status, jawbone health, and perioperative risk in oral and maxillofacial surgery, circulating miR-155 may also serve as a useful adjunct biomarker for risk stratification and multidisciplinary management of COPD patients in craniomaxillofacial settings. However, further studies are recommended. © 2025 Tehran University of Medical Sciences.
Related Docs
View other Related Docs
1. Real-Time Pcr Technique for Diagnosing Respiratory Diseases: Mir-155, Mir-17, Mir-181 Expression, and Copd, Egyptian Journal of Bronchology (2025)
2. Molecular Detection of Chlamydia Pneumoniae, Haemophilus Influenza, and Streptococcus Pneumoniae and Expression of Mir-146, Mir-16, and Mir-221 in Patients With Chronic Obstructive Pulmonary Diseases, Biomedical and Biotechnology Research Journal (2024)
3. Expression Profile and Relationships Between Micrornas As Biomarkers in Copd Patients, Russian Journal of Genetics (2024)
Experts (# of related papers)
View all Related Experts
Naghmeh Bahrami (5)
Reza Meshkani (3)
Other Related Docs
4. Downregulated Microrna-155 Expression in Peripheral Blood Mononuclear Cells of Type 2 Diabetic Patients Is Not Correlated With Increased Inflammatory Cytokine Production, Cytokine (2015)
5. Increasing or Decreasing the Expression of Mir-199, Mir-210 and Mir-143 and the Effect on Cell Growth, Apoptosis and Angiogenesis Through the Expression of Target Genes in Non-Small Cell Lung Cancer, Minerva Respiratory Medicine (2022)
6. Expression of Microrna-155 in Patients With Non-Hodgkin Lymphoma, Coronavirus Disease 2019, or Both: A Cross-Sectional Study, Iranian Journal of Medical Sciences (2023)
7. Assessment of Mir-181B-5P, Mir-23A-3P, Bcl-2, and Il-6 in Peripheral Blood Mononuclear Cells of Autistic Patients; Likelihood of Reliable Biomarkers, Iranian Journal of Allergy# Asthma and Immunology (2020)
8. Over Expression of Circulating Mir-155 Predicts Prognosis in Diffuse Large B-Cell Lymphoma, Leukemia Research (2018)
9. Expression of Circulatory Microrna-155 in Non-Hodgkin Lymphomas and Rheumatoid Arthritis, Medical Journal of Tabriz University of Medical Sciences (2022)
10. Diagnostic and Prognostic Accuracy of Mirnas in Pancreatic Cancer: A Systematic Review and Meta-Analysis, Journal of Cellular and Molecular Medicine (2025)
11. Expression of Mir-155 and Cea and Vegf Proteins As Diagnostic Markers in Early Stages of Non-Small Cell Lung Cancer in Peripheral Blood, Tanaffos (2024)
12. Predictive Inflammation-Related Micrornas for Cardiovascular Events Following Early-Onset Coronary Artery Disease, Archives of Medical Research (2021)
13. Association of Blood Mir-15A, Mir-146A and Mir-200B Levels With Stages of Diabetic Retinopathy, Scientific Reports (2025)
14. Expression Analysis of Microrna-125 in Patients With Polycythemia Vera and Essential Thrombocythemia and Correlation With Jak2 Allele Burden and Laboratory Findings, International Journal of Laboratory Hematology (2015)
15. Investigating the Role of Uric Acid and Uric Acid-To-Creatinine Ratio As a Predictive Factor of Chronic Obstructive Pulmonary Disease Exacerbation in 2019, Clinical Respiratory Journal (2023)
16. Effects of Chemoradiotherapy on Plasma Oncogenic Mirnas As Biomarkers in Cervical Cancer Patients: A Prospective Observational Study, Science Progress (2025)
17. Evaluation of Mir-181B and Mir-126-5P Expression Levels in T2dm Patients Compared to Healthy Individuals: Relationship With Nf-Κb Gene Expression; [Evaluacion De Los Niveles De Expresion De Mir-181B Y Mir-126-5P En Pacientes Con Dmt2 Comparados Con Personas Sanas: Relacion Con La Expresion Del Gen Nf-Κb], Endocrinologia# Diabetes y Nutricion (2020)
18. Differentially Expressed Mir-152, a Potential Biomarker for In-Stent Restenosis (Isr) in Peripheral Blood Mononuclear Cells (Pbmcs) of Coronary Artery Disease (Cad) Patients, Nutrition# Metabolism and Cardiovascular Diseases (2021)
19. The Rs2910164 Variant Is Associated With Reduced Mir-146A Expression But Not Cytokine Levels in Patients With Type 2 Diabetes, Journal of Endocrinological Investigation (2018)
20. Decreased Serum Level of Mir-155 Is Associated With Obesity and Its Related Metabolic Traits, Clinical Laboratory (2018)